Results 91 to 100 of about 22,158 (212)
Abstract Aim To explore the lived experiences of parents of children at risk of type 1 diabetes (T1D) undergoing repeated blinded continuous glucose monitoring (CGM). Method Since 2021, children with persistent islet autoimmunity in the Environmental Determinants of Islet Autoimmunity (ENDIA) study have been invited to participate in a sub‐study ...
Alexandra S. Tully +15 more
wiley +1 more source
This study evaluated serum miRNAs as biomarkers in adult patients with SPIDDM. Serum miRNAs were measured at the time of SPIDDM (probable) diagnosis, and miR‐150‐5p was inversely associated with CPI at the last outpatient visit, suggesting its potential utility for predicting subsequent insulin secretory decline.
Hideyuki Okuma +4 more
wiley +1 more source
Malignant Insulinoma in Childhood
Pancreatic tumors constitute a rare surgical problem in infancy and childhood. Insulinomas are rare in all age groups with an estimated incidence of one per 250,000 person-years and even rarer in childhood. We report a 10 year-old girl with malignant insulinoma. The presenting symptom was hypoglycemic attacks. Laboratory investigation demonstrated that
Karachaliou, F.-H. +7 more
openaire +3 more sources
Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors
Abstract The incidence of duodenal and pancreatic neuroendocrine tumors (dpNETs) has increased substantially in recent years. These tumors may be due to syndromic hereditary predisposition syndromes: multiple endocrine neoplasia type 1 (MEN1) or 4 (MEN4), Von Hippel–Lindau disease (VHL), neurofibromatosis type 1 (NF1), or tuberous sclerosis complex ...
Théo Charnay +13 more
wiley +1 more source
ABSTRACT Primary hepatic neuroendocrine neoplasms (PHNENs) are exceedingly rare. Published evidence often lacks adequate clinicopathological support for a primary hepatic origin and uses inconsistent historical terminology. Previous reviews have pooled well‐differentiated neuroendocrine tumours (NETs), poorly differentiated neuroendocrine carcinomas ...
Marcello Maestri +6 more
wiley +1 more source
Insulinoma and anaesthetic implications
Insulinoma is a rare neuroendocrine tumour of the pancreas , which is usually small, solitary and benign. It may be part of the multiple endocrine neoplasia type 1 syndrome. It is diagnosed by clinical, biochemical and imaging modalities.
Pallavi Somkuwar +2 more
core +1 more source
Abstract Objective To describe the perioperative and long‐term outcomes of dogs with massive hepatocellular carcinoma (HCC) in the right hepatic division causing compression or involvement of the caudal vena cava (CVC) treated with right divisional hepatectomy using temporary caval occlusion (TCO). Study design Retrospective case series.
Kumiko Ishigaki +6 more
wiley +1 more source
Canine insulinoma is the neoplastic growth of the beta cells of the pancreas. in man 90% of the growths are found to be benign while in the dog reports say 69-81% of the growths are malignant (2,7).
Siddons, Earl, Carithers, R.
core
Cognitive Impairment in Insulinoma, Consequence of a Delayed Diagnosis: A Case Report
The diagnosis of insulinoma is often delayed and this usually results with complications such as cognitive impairment. A 60 year old man who had history of aggressive behaviour and attacks of unconciousness was evaluated for hypoglycemia.
Dilek Soysal +6 more
doaj +2 more sources
Insulinoma May Present as Epilepsy: A Case Report [PDF]
Hypoglycemia developing linked to insulinoma may present with clinical findings similar to epileptic seizures and electroencephalography findings may be in accordance with epilepsy.
Sen, Halil Murat +3 more
core +1 more source

